Literature DB >> 14715443

MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

R Aguilar Hernández1, M J Sánchez De Las Matas, C Arriagada, C Barcia, P Caviedes, M T Herrero, J Segura-Aguilar.   

Abstract

We have tested the idea that oxidative metabolism of dopamine may be involved in MPTP toxicity using the RCSN-3 cell line derived from the substantia nigra of an adult rat. Treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (10 microM), MPTP combined with 40 microM dicoumarol (an inhibitor of DT-diaphorase) and dicoumarol alone, did not induce toxicity in RCSN-3 cells after 72 h incubation. The lack of toxicity in MPTP-treated RCSN-3 cells may be explained by the fact that they are unable to metabolize MPTP to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinium ion (MPP+ as determined by HPLC. Incubation for 72 h with 100 microM MPP+ induced a 6.6 +/- 1.4% cell death of RCSN-3 cells compared to 3.5 +/- 0.4 observed in control cells. However, when the cells were treated with 100 microM MPP+ and 40 microM dicoumarol, cell death increased 4-fold compared to that of cells treated solely with MPP+ (27 +/- 2%; P<0.001). Under these conditions, a significant increase in DNA fragmentation (3-fold compared to MPP+ alone; P<0.01) and in calpain activation (P<0.05 compared to control) was evident. The inhibition of DT-diaphorase by dicoumarol supports the idea that oxidative metabolism of dopamine is involved in MPP+ toxicity in RCSN-3 cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715443     DOI: 10.1007/bf03033169

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  24 in total

1.  Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases.

Authors:  B Knepper-Nicolai; J Savill; S B Brown
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

2.  Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase.

Authors:  S Baez; Y Linderson; J Segura-Aguilar
Journal:  Biochem Mol Med       Date:  1995-02

3.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  J W Langston; P A Ballard
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

4.  On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

Authors:  J Segura-Aguilar; C Lind
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

5.  Neuromelanin and Parkinson's disease.

Authors:  C D Marsden
Journal:  J Neural Transm Suppl       Date:  1983

6.  Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach.

Authors:  B G Rosser; S P Powers; G J Gores
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

7.  Neuromelanin accumulation with age in catecholaminergic neurons from Macaca fascicularis brainstem.

Authors:  M T Herrero; E C Hirsch; A Kastner; M R Luquin; F Javoy-Agid; L M Gonzalo; J A Obeso; Y Agid
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

8.  Possible role of neuromelanin in the pathogenesis of Parkinson's disease.

Authors:  D M Mann; P O Yates
Journal:  Mech Ageing Dev       Date:  1983-02       Impact factor: 5.432

9.  The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system.

Authors:  J Segura-Aguilar; D Metodiewa; S Baez
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

10.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  6 in total

Review 1.  Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.

Authors:  Irmgard Paris; Sergio Cardenas; Jorge Lozano; Carolina Perez-Pastene; Rebecca Graumann; Alejandra Riveros; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

2.  The catecholaminergic RCSN-3 cell line: a model to study dopamine metabolism.

Authors:  Irmgard Paris; Jorge Lozano; Sergio Cardenas; Carolina Perez-Pastene; Katherine Saud; Patricio Fuentes; Pablo Caviedes; Alexies Dagnino-Subiabre; Rita Raisman-Vozari; Takeshi Shimahara; John P Kostrzewa; David Chi; Richard M Kostrzewa; Raul Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2008 May-Jun       Impact factor: 3.911

Review 3.  Neurotoxins and neurotoxic species implicated in neurodegeneration.

Authors:  Juan Segura Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.

Authors:  Jillienne C Touchette; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  Neurosci Lett       Date:  2015-12-15       Impact factor: 3.046

5.  Molecular and neurochemical mechanisms in PD pathogenesis.

Authors:  Irmgard Paris; Jorge Lozano; Carolina Perez-Pastene; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2009-05-20       Impact factor: 3.911

Review 6.  Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.